Shenghua Pharmaceutical was established in 2009 in Zhangjiang Pharma Valley, Pudong New Area, Shanghai. Equipped with advanced analytical instruments such as LCMS and GCMS, as well as a continuous flow reaction and online analysis technology center, the company is driven by industrialization goals. Leveraging the advantages of its technology center, it is dedicated to the process development and production of active pharmaceutical ingredients (APIs) and intermediates, amino acid derivatives and peptides, and fluorine-containing compounds. Shenghua implements a diversified strategy for pharmaceutical chemical products and resources, with an equity investment in Jiangxi Kening Technology Co., Ltd., which specializes in the production of fluorine gas and fluorine-containing chemicals. The under-construction Sichuan Shenghua Pharmaceutical, located in the Luzhou Medical Industrial Park in Sichuan, serves as a modern GMP industrialization base capable of meeting production tasks from kilogram to ton scale, accepting global CRO and CMO business.